Evidence map›Paper›PMID 21619634›Full record

ArticleBiomedical engineering online2011

Nonlinear observer output-feedback MPC treatment scheduling for HIV.

Ryan Zurakowski

Abstract read
In one paragraph

Article in Biomedical engineering online, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Modeling Kick-Kill Strategies toward HIV Cure.Frontiers in immunology · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ryan ZurakowskiDepartment of Electrical and Computer Engineering, University of Delaware, Newark, DE 19716, USA. ryanz@udel.edu

Funding

Analysis of Differential Resistance Emergence Risk for Differential Treatment AppR21AI078842 · NIAID · UNIVERSITY OF DELAWARE · PI ZURAKOWSKI, RYAN M · 2009 to 2010
$396k
Nonlinear Control and HIV TherapyR21AI057071 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI TEEL, ANDREW R · 2003 to 2004
$390k
NIAID NIH HHS R21 AI057071NIAID NIH HHS R21 AI078842
6 · The paper itself

Abstract

backgroundMathematical models of the immune response to the Human Immunodeficiency Virus demonstrate the potential for dynamic schedules of Highly Active Anti-Retroviral Therapy to enhance Cytotoxic Lymphocyte-mediated control of HIV infection.

methodsIn previous work we have developed a model predictive control (MPC) based method for determining optimal treatment interruption schedules for this purpose. In this paper, we introduce a nonlinear observer for the HIV-immune response system and an integrated output-feedback MPC approach for implementing the treatment interruption scheduling algorithm using the easily available viral load measurements. We use Monte-Carlo approaches to test robustness of the algorithm.

resultsThe nonlinear observer shows robust state tracking while preserving state positivity both for continuous and discrete measurements. The integrated output-feedback MPC algorithm stabilizes the desired steady-state. Monte-Carlo testing shows significant robustness to modeling error, with 90% success rates in stabilizing the desired steady-state with 15% variance from nominal on all model parameters.

conclusionsThe possibility of enhancing immune responsiveness to HIV through dynamic scheduling of treatment is exciting. Output-feedback Model Predictive Control is uniquely well-suited to solutions of these types of problems. The unique constraints of state positivity and very slow sampling are addressable by using a special-purpose nonlinear state estimator, as described in this paper. This shows the possibility of using output-feedback MPC-based algorithms for this purpose.

Indexed as

FeedbackModels, BiologicalAnti-HIV AgentsDrug Administration ScheduleHIV InfectionsHumansNonlinear DynamicsAnti-HIV Agents

Identifiers

PMID21619634
PMCPMC3127993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.